Benefits of Stereotaxis Robotic Technology in COVID-19 Patient Highlighted in Publication
July 13, 2020 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 13, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in...
Stereotaxis to be Added to the Russell 2000® and Russell 3000® Indexes
June 22, 2020 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 22, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that the company...
Stereotaxis to Present at Cowen 5th Annual FutureHealth Conference
June 18, 2020 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 18, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Pioneering Efforts in TeleRobotic Surgery Focus of Webcast Symposium on June 20th
June 10, 2020 09:00 ET
|
Stereotaxis, Inc.
New Leadership Council Announced to Advance Adoption of TeleRoboticsFirst Bi-Directional TeleRobotic Surgery Broadcast LiveST. LOUIS, June 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the...
Stereotaxis Robotic Technology Now Referenced In Over 400 Scientific Publications
June 02, 2020 09:00 ET
|
Stereotaxis, Inc.
Over 400 scientific publications now document clinical benefits of Stereotaxis robotic technologyMost recent publication reviews outcomes of 1,003 consecutive robotic procedures at a single center ...
Stereotaxis Announces $15 Million Common Stock Financing
May 26, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has...
Stereotaxis Reports 2020 First Quarter Financial Results
May 05, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 05, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis to Report First Quarter 2020 Financial Results on May 5, 2020
April 30, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 30, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Reports 2019 Full Year Financial Results
March 10, 2020 08:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial...
Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System
March 06, 2020 08:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received...